Inflammatory response following diffuse axonal injury

International Journal of Medical Sciences

Volumn 10, Issue 5, 2013, Pages 515-521

  Lin, Yu ^a   Wen, Liang ^b  

^a ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diffuse axonal injury; Inflammatory response; Traumatic brain injury

Indexed keywords

CYCLOSPORIN A; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; MYELIN; SUBSTANCE P ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

AXONAL INJURY; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; EXPERIMENTAL ANIMAL; HEAD INJURY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MICROGLIA; NONHUMAN; PROTEIN FAMILY; REVIEW;

DIFFUSE AXONAL INJURY; INFLAMMATORY RESPONSE.; TRAUMATIC BRAIN INJURY;

AXONS; CRANIOCEREBRAL TRAUMA; DIFFUSE AXONAL INJURY; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875179766     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5423     Document Type: Review

References (95)

1. Schmidt OI, Heyde CE, Ertel W, et al. Closed head injury-an inflammatory disease? Brain Res Brain Res Rev. 2005; 48:388-399.
2. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38:1336-1345.
3. Pradilla G, Chaichana KL, Hoang S, et al. Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21:365-379.
4. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009;7:97.
5. Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009; 6:e1000145.
6. Friese MA, Montalban X, Willcox N, et al. The value of animal models for drug development in multiple sclerosis. Brain. 2006;129:1940-1952.
7. Lynch NJ, Willis CL, Nolan CC, et al. Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol. 2004;40:709-716.
8. Quattrocchi KB, Miller CH, Wagner FC, Jr., et al. Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors. J Neurosurg. 1992;77:694-699.
9. Czigner A, Mihaly A, Farkas O, et al. Kinetics of the cellular immune response following closed head injury. Acta Neurochir (Wien). 2007;149:281-289.
10. Mace BE, Wang H, Lynch JR, et al. Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway. Neurol Res. 2007;29:243-250.
11. Zhang J, Rivest S. Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J Neurochem. 2001;76:855-864.
12. Vink R, Donkin JJ, Cruz MI, et al. A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. J Am Coll Nutr. 2004;23:538S-540S.
13. LaPar DJ, Rosenberger LH, Walters DM, et al. Severe traumatic head injury affects systemic cytokine expression. J Am Coll Surg. 2012;214:478-486.
14. Solomon D, Kim B, Scultetus A, et al. The effect of rFVIIa on pro- and anti-inflammatory cytokines in serum and cerebrospinal fluid in a swine model of traumatic brain injury. Cytokine. 2011;54:20-23.
15. Helmy A, Carpenter KL, Menon DK, et al. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2011;31:658-670.
16. Li XY, Feng DF. Diffuse axonal injury: novel insights into detection and treatment. J Clin Neurosci. 2009;16:614-619.
17. Li J, Li XY, Feng DF, et al. Biomarkers associated with diffuse traumatic axonal injury: exploring pathogenesis, early diagnosis, and prognosis. J Trauma. 2010;69:1610-1618.
18. Sharp DJ, Ham TE. Investigating white matter injury after mild traumatic brain injury. Curr Opin Neurol. 2011;24:558-563.
19. Vlodavsky E, Palzur E, Feinsod M, et al. Evaluation of the apoptosis-related proteins of the BCL-2 family in the traumatic penumbra area of the rat model of cerebral contusion, treated by hyperbaric oxygen therapy: a quantitative immunohistochemical study. Acta Neuropathol. 2005;110:120-126.
20. Soustiel JF, Vlodavsky E, Zaaroor M. Relative effects of mannitol and hypertonic saline on calpain activity, apoptosis and polymorphonuclear infiltration in traumatic focal brain injury. Brain Res. 2006;1101:136-144.
21. Kim JV, Dustin ML. Innate response to focal necrotic injury inside the blood-brain barrier. J Immunol. 2006;177:5269-5277.
22. Friedrich DH, Plesnila N, Eriskat J, et al. Cerebral blood flow and the secondary growth of brain tissue necrosis after trauma. Acta Neurochir Suppl. 2000;76:257-259.
23. Ross DT, Graham DI, Adams JH. Selective loss of neurons from the thalamic reticular nucleus following severe human head injury. J Neurotrauma. 1993;10:151-165.
24. Ahn YH, Kim SH, Han BS, et al. Focal lesions of the corticospinal tract demonstrated by diffusion tensor imaging in patients with diffuse axonal injury. NeuroRehabilitation. 2006;21:239-243.
25. Chang MC, Jang SH. Corpus callosum injury in patients with diffuse axonal injury: a diffusion tensor imaging study. NeuroRehabilitation. 2010;26:339-345.
26. Farkas O, Povlishock JT. Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res. 2007;161:43-59.
27. Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil. 2005;20:76-94.
28. Grady MS, McLaughlin MR, Christman CW, et al. The use of antibodies targeted against the neurofilament subunits for the detection of diffuse axonal injury in humans. J Neuropathol Exp Neurol. 1993;52:143-152.
29. Christman CW, Grady MS, Walker SA, et al. Ultrastructural studies of diffuse axonal injury in humans. J Neurotrauma. 1994;11:173-186.
30. Buki A, Siman R, Trojanowski JQ, et al. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol. 1999;58:365-375.
31. Buki A, Okonkwo DO, Wang KK, et al. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci. 2000;20:2825-2834.
32. Wang HC, Ma YB. Experimental models of traumatic axonal injury. J Clin Neurosci. 2010;17:157-162.
33. Morganti-Kossmann MC, Yan E, Bye N. Animal models of traumatic brain injury: is there an optimal model to reproduce human brain injury in the laboratory? Injury. 2010;41 Suppl 1:S10-S13.
34. Foda MA, Marmarou A. A new model of diffuse brain injury in rats. Part II: Morphological characterization. J Neurosurg. 1994;80:301-313.
35. Kelley BJ, Lifshitz J, Povlishock JT. Neuroinflammatory responses after experimental diffuse traumatic brain injury. J Neuropathol Exp Neurol. 2007;66:989-1001.
36. Oehmichen M, Theuerkauf I, Meissner C. Is traumatic axonal injury (AI) associated with an early microglial activation? Application of a double-labeling technique for simultaneous detection of microglia and AI. Acta Neuropathol. 1999;97:491-494.
37. Venkatesan C, Chrzaszcz M, Choi N, et al. Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J Neuroinflammation. 2010;7:32.
38. Yu I, Inaji M, Maeda J, et al. Glial cell-mediated deterioration and repair of the nervous system after traumatic brain injury in a rat model as assessed by positron emission tomography. J Neurotrauma. 2010;27:1463-1475.
39. Wilson S, Raghupathi R, Saatman KE, et al. Continued in situ DNA fragmentation of microglia/macrophages in white matter weeks and months after traumatic brain injury. J Neurotrauma. 2004;21:239-250.
40. Csuka E, Hans VH, Ammann E, et al. Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport. 2000;11:2587-2590.
41. Penkowa M, Giralt M, Lago N, et al. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol. 2003;181:130-148.
42. Fux M, van Rooijen N, Owens T. Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation. J Neuroimmunol. 2008;203:64-72.
43. Scholz M, Cinatl J, Schadel-Hopfner M, et al. Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev. 2007;27:401-416.
44. Farias S, Frey LC, Murphy RC, et al. Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury. J Neurotrauma. 2009;26:1977-1986.
45. Bye N, Carron S, Han X, et al. Neurogenesis and glial proliferation are stimulated following diffuse traumatic brain injury in adult rats. J Neurosci Res. 2011;89:986-1000.
46. Hellewell SC, Yan EB, Agyapomaa DA, et al. Post-traumatic hypoxia exacerbates brain tissue damage: analysis of axonal injury and glial responses. J Neurotrauma. 2010;27:1997-2010.
47. Morganti-Kossmann MC, Rancan M, Stahel PF, et al. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care. 2002;8:101-105.
48. Shohami E, Novikov M, Bass R, et al. Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab. 1994;14:615-619.
49. Taupin V, Toulmond S, Serrano A, et al. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol. 1993;42:177-185.
50. Kossmann T, Stahel PF, Lenzlinger PM, et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab. 1997;17:280-289.
51. Balasingam V, Tejada-Berges T, Wright E, et al. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci. 1994;14:846-856.
52. Holmin S, Schalling M, Hojeberg B, et al. Delayed cytokine expression in rat brain following experimental contusion. J Neurosurg. 1997;86:493-504.
53. Ciallella JR, Ikonomovic MD, Paljug WR, et al. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J Neurotrauma. 2002;19:1555-1567.
54. Lu KT, Wang YW, Wo YY, et al. Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett. 2005;386:40-45.
55. Campbell SJ, Deacon RM, Jiang Y, et al. Over expression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behavior. Neurobiol Dis. 2007;27:151-163.
56. Hans VH, Kossmann T, Lenzlinger PM, et al. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab. 1999;19:184-194.
57. Rhodes JK, Andrews PJ, Holmes MC, et al. Expression of interleukin-6 messenger RNA in a rat model of diffuse axonal injury. Neurosci Lett. 2002;335:1-4.
58. Tilg H, Trehu E, Atkins MB, et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994;83:113-118.
59. Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878-888.
60. Jawa RS, Anillo S, Huntoon K, et al. Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. J Intensive Care Med. 2011;26:73-87.
61. Kita T, Tanaka T, Tanaka N, et al. The role of tumor necrosis factor-alpha in diffuse axonal injury following fluid-percussive brain injury in rats. Int J Legal Med 2000;113:221-228.
62. Khuman J, Meehan WP, 3rd, Zhu X, et al. Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J Cereb Blood Flow Metab. 2011;31:778-789.
63. Yan EB, Hellewell SC, Bellander BM, et al. Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury. J Neuroinflammation. 2011;8:147.
64. Hundsberger H, Verin A, Wiesner C, et al. TNF: a moonlighting protein at the interface between cancer and infection. Front Biosci. 2008;13:5374-5386.
65. Katschinski DM, Robins HI, Schad M, et al. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells. Cancer Res. 1999;59:3404-3410.
66. Akassoglou K, Bauer J, Kassiotis G, et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol. 1998;153:801-813.
67. Ladiwala U, Lachance C, Simoneau SJ, et al. p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci. 1998;18:1297-1304.
68. Previtali SC, Archelos JJ, Hartung HP. Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis. A central role for TNF-alpha. Am J Pathol. 1997;151:1425-1435.
69. Greenwood J, Etienne-Manneville S, Adamson P, et al. Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol. 2002;38:315-322.
70. Hausmann EH, Berman NE, Wang YY, et al. Selective chemokine mRNA expression following brain injury. Brain Res. 1998;788:49-59.
71. Rhodes JK, Sharkey J, Andrews PJ. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J Neurotrauma. 2009;26:507-525.
72. Rancan M, Otto VI, Hans VH, et al. Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats. J Neurosci Res. 2001;63:438-446.
73. Schilling M, Strecker JK, Ringelstein EB, et al. The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res. 2009;1289:79-84.
74. Matzer SP, Zombou J, Sarau HM, et al. A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice. Immunobiology. 2004;209:225-233.
75. Ueta M, Sotozono C, Yokoi N, et al. Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders. PLoS One. 2011;6:e25209.
76. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120.
77. Brian JE, Jr., Moore SA, Faraci FM. Expression and vascular effects of cyclooxygenase-2 in brain. Stroke. 1998;29:2600-2606.
78. Tardieu D, Jaeg JP, Deloly A, et al. The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis. 2000;21:973-976.
79. Parsadaniantz SM, Lebeau A, Duval P, et al. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat. J Neuroendocrinol. 2000;12:766-773.
80. Hickey RW, Adelson PD, Johnnides MJ, et al. Cyclooxygenase-2 activity following traumatic brain injury in the developing rat. Pediatr Res. 2007;62:271-276.
81. Kunz T, Marklund N, Hillered L, et al. Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat. J Neurotrauma. 2002;19:1051-1064.
82. Cernak I, O'Connor C, Vink R. Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp Brain Res. 2002;147:193-199.
83. Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res Brain Res Rev. 1998;27:243-256.
84. Stahel PF, Kossmann T, Morganti-Kossmann MC, et al. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Brain Res Mol Brain Res. 1997;50:205-212.
85. Trembovler V, Beit-Yannai E, Younis F, et al. Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat. J Interferon Cytokine Res. 1999;19:791-795.
86. Yu JX, Bradt BM, Cooper NR. Constitutive expression of proinflammatory complement components by subsets of neurons in the central nervous system. J Neuroimmunol. 2002;123:91-101.
87. Risling M, Plantman S, Angeria M, et al. Mechanisms of blast induced brain injuries, experimental studies in rats. Neuroimage. 2011;54 Suppl 1:S89-S97.
88. Davidsson JAM, Risling M. Injury threshold for sagittal plane rotational induced diffuse axonal injuries. In: 2009 International ircobi conference on the biomechanics of injury (Schmitt, K. U., ed). YORK (UK): IRCOBI Conference. 2009;:43-56.
89. Sun X, Wang X, Chen T, et al. Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One. 2010;5:e9380.
90. Yang XF, Wang H, Wen L. From myelin debris to inflammatory responses: a vicious circle in diffuse axonal injury. Med Hypotheses. 2011;77:60-62.
91. Okonkwo DO, Melon DE, Pellicane AJ, et al. Dose-response of cyclosporin A in attenuating traumatic axonal injury in rat. Neuroreport. 2003;14:463-466.
92. Tamas A, Zsombok A, Farkas O, et al. Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats. J Neurotrauma. 2006;23:686-695.
93. Donkin JJ, Cernak I, Blumbergs PC, et al. A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. J Neurotrauma. 2011;28:217-224.
94. Staal JA, Dickson TC, Chung RS, et al. Cyclosporin-A treatment attenuates delayed cytoskeletal alterations and secondary axotomy following mild axonal stretch injury. Dev Neurobiol. 2007;67:1831-1842.
95. Homsi S, Piaggio T, Croci N, et al. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study. J Neurotrauma. 2010;27:911-921.